CareDx, Inc. (CDNA)

Price$22.80

Value ScoreD

Growth ScoreB

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)28.87%

Price vs S&P 500 (4W)1.17%

VGM Score61.50

Market Capitalization$1.16B

P/E Ratio (Annual)18.34x

All Metrics

P/CF (Annual)27.63x

Book Value / Share (Quarterly)$6.11

P/TBV (Annual)3.57x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)5.68%

Cash Flow / Share (Quarterly)$1.25

Price vs S&P 500 (YTD)10.19%

Gross Margin (TTM)68.88%

Net Profit Margin (TTM)-1.98%

EPS (TTM)$-0.15

10-Day Avg Trading Volume0.70M

EPS Excl Extra (TTM)$-0.15

Revenue Growth (5Y)14.59%

EPS (Annual)$-0.40

ROI (Annual)-7.05%

Gross Margin (Annual)67.55%

Net Profit Margin (5Y Avg)-18.38%

Cash / Share (Quarterly)$3.65

P/E Basic Excl Extra (TTM)15.86x

Revenue Growth QoQ (YoY)38.99%

P/E Normalized (Annual)18.34x

ROA (Last FY)-5.17%

Revenue Growth TTM (YoY)19.17%

EBITD / Share (TTM)$-0.26

ROE (5Y Avg)-18.07%

Operating Margin (TTM)-3.93%

Cash Flow / Share (Annual)$0.70

P/B Ratio3.70x

P/B Ratio (Quarterly)2.84x

Net Income / Employee (Annual)$-28,100

EV / Revenue (TTM)2.62x

Net Interest Coverage (TTM)-15.50x

ROA (TTM)-1.93%

EV / EBITDA (TTM)20.63x

EPS Incl Extra (Annual)$-0.40

Current Ratio (Annual)2.86x

Quick Ratio (Quarterly)2.93x

3-Month Avg Trading Volume0.68M

52-Week Price Return37.80%

EV / Free Cash Flow (Annual)30.57x

P/E Incl Extra (TTM)15.86x

Revenue / Employee (TTM)$542,500

Tangible BV / Share (Quarterly)$5.49

P/S Ratio (Annual)3.06x

Asset Turnover (Annual)0.92x

52-Week High$23.24

Operating Margin (5Y Avg)-20.34%

EPS Excl Extra (Annual)$-0.40

CapEx CAGR (5Y)-8.66%

Tangible BV CAGR (5Y)3.05%

26-Week Price Return44.80%

Quick Ratio (Annual)2.45x

13-Week Price Return21.25%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)3.40x

Enterprise Value$1.08B

Revenue / Share Growth (5Y)11.51%

Asset Turnover (TTM)0.97x

Book Value / Share Growth (5Y)1.15%

Revenue / Employee (Annual)$499,100

Inventory Turnover (Annual)5.33x

Pretax Margin (Annual)-5.55%

Cash / Share (Annual)$3.48

3-Month Return Std Dev69.94%

Gross Margin (5Y Avg)66.12%

Net Income / Employee (TTM)$-10,800

ROE (Last FY)-7.05%

Net Interest Coverage (Annual)-12.00x

EPS Basic Excl Extra (Annual)$-0.40

P/FCF (TTM)18.10x

Receivables Turnover (TTM)7.11x

EV / Free Cash Flow (TTM)16.88x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.15

Receivables Turnover (Annual)7.08x

ROI (TTM)-2.61%

P/S Ratio (TTM)2.81x

Pretax Margin (5Y Avg)-18.41%

Revenue / Share (Annual)$7.13

Tangible BV / Share (Annual)$5.33

Forward P/E22.50x

Free OCF CAGR (5Y)8.97%

Price vs S&P 500 (52W)9.60%

P/E Ratio (TTM)15.86x

Year-to-Date Return21.13%

5-Day Price Return5.50%

EPS Normalized (Annual)$-0.40

ROA (5Y Avg)-10.95%

Net Profit Margin (Annual)-5.62%

Month-to-Date Return9.66%

Cash Flow / Share (TTM)$-1.42

EBITD / Share (Annual)$-0.53

Operating Margin (Annual)-8.10%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)15.92x

ROI (5Y Avg)-18.07%

P/E Excl Extra (TTM)15.86x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.15

P/TBV (Quarterly)3.16x

P/B Ratio (Annual)3.20x

Inventory Turnover (TTM)5.21x

Pretax Margin (TTM)-1.94%

Book Value / Share (Annual)$5.95

Price vs S&P 500 (13W)11.51%

Beta2.50x

P/FCF (Annual)32.76x

Revenue / Share (TTM)$7.77

ROE (TTM)-2.61%

52-Week Low$10.96

vGradeD

gGradeB

mGradeB

vgmGradeB

Show chart for

Earnings Surprise History

Q1 260.34est. 0.14

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

3.86

3.93

4.00

Industry Peers — Health Services(28)

Symbol	Value Score	Growth Score	Momentum Score	Price
CDNACareDx, Inc.	D	B	B	$22.80
NTRANatera, Inc. Common Stock	F	A	B	$218.81
DGXQuest Diagnostics Inc.	C	D	C	$192.20
LHLabcorp Holdings Inc.	C	D	C	$256.87
EXASExact Sciences Corp	F	B	B	$0.00
GHGuardant Health, Inc. Common Stock	F	A	A	$129.14
CELCCelcuity Inc. Common Stock	—	—	B	$122.96
CAICaris Life Sciences, Inc. Common Stock	F	F	C	$16.45
RDNTRadNet, Inc. Common Stock	D	C	D	$52.89
VCYTVeracyte, Inc.	D	A	B	$48.18
GRALGRAIL, Inc. Common Stock	D	A	B	$64.40

About

CareDx is a precision medicine company providing genomics-based testing solutions for transplant patients. Its primary products include AlloSure and AlloMap, diagnostic tests that monitor transplant function and rejection risk. The company generates most revenue from testing services in the United States, serving transplant recipients and caregivers throughout the patient journey.